Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics ...

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...

In Pluribus, Rhea Seehorn stars as Carol Sturka—a disillusioned romance novelist who becomes “the most miserable person on Earth” and one of the very few immune to the hive-like virus sweeping ...

Both tobevibart (a monoclonal antibody) and elebsiran (a small interfering RNA) target hepatitis B virus surface antigen (HBsAg). Their efficacy and safety in the treatment of chronic hepatitis D ...

WASHINGTON -- An investigational dual therapy appeared to show antiviral activity in patients with chronic hepatitis D virus ...

The devastating retrovirus HTLV-1 has eluded scientists for decades. Overcoming chronic funding and other challenges, ...

Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...